Zobrazeno 61 - 70
of 929
pro vyhledávání: '"Keunchil Park"'
Autor:
Eui-Cheol Shin, Myung-Ju Ahn, Keunchil Park, Su-Hyung Park, Young Joo Min, Jaekyung Cheon, Jin Seok Ahn, Se-Hoon Lee, Jong-Mu Sun, Jiae Koh, Bo Mi Ku, Jinhyun Cho, Kyung Hwan Kim
Supplementary Figure S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6deb775daeca6dc6e83bda34b3b53230
https://doi.org/10.1158/1078-0432.22473144.v1
https://doi.org/10.1158/1078-0432.22473144.v1
Autor:
Alexander Drilon, Suhyun Kang, Xin Huang, Jennifer F. Kherani, Edward Y. Zhu, Christian Rolfo, Oliver Gautschi, Benjamin Besse, Haruko Daga, Keunchil Park, Lyudmila Bazhenova, Yu Jung Kim, Jared Weiss, Caroline E. McCoach, Herbert H. Loong, Byoung Chul Cho, Dwight H. Owen, Daniel S.W. Tan, Geoffrey R. Oxnard, Justin F. Gainor, Vivek Subbiah
LIBRETTO-001 Trial Profile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::470331d9c2583519123c1ee3a18c2d05
https://doi.org/10.1158/1078-0432.22481307
https://doi.org/10.1158/1078-0432.22481307
Autor:
Heather Wakelee, Keunchil Park, Andrew R. Allen, Mitch Raponi, Lindsey Rolfe, Darrin Despain, Shannon Matheny, Patrick O'Donnell, Sean Chien, Lin Wu, Cloud Paweletz, Shirish Gadgeel, D. Ross Camidge, Benjamin Solomon, Jean-Charles Soria, David Spigel, Leora Horn, Philipp Angenendt, Wei Wen, Krzysztof Konopa, Lecia V. Sequist, Elaina Mann, Jong-Mu Sun, Jonathan W. Goldman, Chris Karlovich
Supplementary Tables S1-7. Supplementary Table S1. Clinical characteristics of patients in the present analysis. Supplementary Table S2. Plasma/tissue concordance results for del19 and L858R mutations. Supplementary Table S3. EGFR mutations identifie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b3dc6a18c5e310afed59143a08002fc
https://doi.org/10.1158/1078-0432.22458872.v1
https://doi.org/10.1158/1078-0432.22458872.v1
Autor:
Eui-Cheol Shin, Myung-Ju Ahn, Keunchil Park, Su-Hyung Park, Young Joo Min, Jaekyung Cheon, Jin Seok Ahn, Se-Hoon Lee, Jong-Mu Sun, Jiae Koh, Bo Mi Ku, Jinhyun Cho, Kyung Hwan Kim
Supplementary Tables S1-S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02719357b423f654378c204f2c050045
https://doi.org/10.1158/1078-0432.22473141
https://doi.org/10.1158/1078-0432.22473141
Autor:
Keunchil Park, Jhingook Kim, Woong-Yang Park, Joungho Han, Myung-Ju Ahn, Jin Seok Ahn, Jong-Mu Sun, Sehhoon Park, Young Mog Shim, Jae Ill Zo, Yong Soo Choi, Hong Kwan Kim, Jong Ho Cho, Sumin Shin, Jae Won Choi, Yeong Jeong Jeon, Je-Gun Joung, Se-Hoon Lee, Yoon-La Choi, Jinyeong Lim, Hyun Ae Jung
Purpose:In early-stage, EGFR mutation–positive (EGFR-M+) non–small cell lung cancer (NSCLC), surgery remains the primary treatment, without personalized adjuvant treatments. We aimed to identify risk factors for recurrence-free survival (RFS) to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58e0755d8a19fad5e9eb85cd5e66e9c6
https://doi.org/10.1158/1078-0432.c.6532326.v1
https://doi.org/10.1158/1078-0432.c.6532326.v1
Autor:
David Planchard, Bo H. Chao, Rebecca R. Hozak, Ling Gao, Sameera R. Wijayawardana, Huzhang Mao, Dae Ho Lee, Joo-Hang Kim, Keunchil Park, Pilar Garrido, Ki Hyeong Lee, James Chih-Hsin Yang, Luis G. Paz-Ares, Helena A. Yu
Patient disposition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::202ce1043c77888a619f4b916e9483a5
https://doi.org/10.1158/1078-0432.22478334.v1
https://doi.org/10.1158/1078-0432.22478334.v1
Autor:
Paul K. Paik, Gordon Otto, Rolf Bruns, Karl-Maria Schumacher, Karin Berghoff, Elif Sikoglu, John Heymach, Christian Britschgi, Maya Gottfried, Melissa Johnson, Frank Griesinger, Keunchil Park, Christine M. Bestvina, Jyoti D. Patel, Yuh-Min Chen, James Chih-Hsin Yang, Hye Ryun Kim, Byoung Chul Cho, Wade T. Iams, Michael Thomas, Egbert F. Smit, Julien Mazieres, Santiago Viteri, Alexis B. Cortot, Jo Raskin, Marina Chiara Garassino, Remi Veillon, Enriqueta Felip, Hiroshi Sakai, Xiuning Le
Purpose:Primary analysis of VISION showed tepotinib had durable clinical activity in patients with MET exon 14 (METex14) skipping non–small cell lung cancer (NSCLC). We present updated outcomes for clinically relevant subgroups.Patients and Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5552ad5b36a619d7db55e5782ec1e34c
https://doi.org/10.1158/1078-0432.c.6531026.v1
https://doi.org/10.1158/1078-0432.c.6531026.v1
Autor:
Heather Wakelee, Keunchil Park, Andrew R. Allen, Mitch Raponi, Lindsey Rolfe, Darrin Despain, Shannon Matheny, Patrick O'Donnell, Sean Chien, Lin Wu, Cloud Paweletz, Shirish Gadgeel, D. Ross Camidge, Benjamin Solomon, Jean-Charles Soria, David Spigel, Leora Horn, Philipp Angenendt, Wei Wen, Krzysztof Konopa, Lecia V. Sequist, Elaina Mann, Jong-Mu Sun, Jonathan W. Goldman, Chris Karlovich
Purpose: The evaluation of plasma testing for the EGFR resistance mutation T790M in NSCLC patients has not been broadly explored. We investigated the detection of EGFR activating and T790M mutations in matched tumor tissue and plasma, mostly from pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fe1cc876e37080c39de4bc75b79f3ae
https://doi.org/10.1158/1078-0432.c.6524060.v1
https://doi.org/10.1158/1078-0432.c.6524060.v1
Autor:
David Planchard, Bo H. Chao, Rebecca R. Hozak, Ling Gao, Sameera R. Wijayawardana, Huzhang Mao, Dae Ho Lee, Joo-Hang Kim, Keunchil Park, Pilar Garrido, Ki Hyeong Lee, James Chih-Hsin Yang, Luis G. Paz-Ares, Helena A. Yu
Purpose:We report the final analysis of JVDL (NCT02789345), which examined the combination of the EGFR tyrosine kinase inhibitor (TKI) osimertinib plus the VEGFR2-directed antibody ramucirumab in patients with T790M-positive EGFR-mutant non–small c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc2a6c98a0501382e628762860b1ae1
https://doi.org/10.1158/1078-0432.c.6529920
https://doi.org/10.1158/1078-0432.c.6529920
Autor:
Keunchil Park, Jhingook Kim, Woong-Yang Park, Joungho Han, Myung-Ju Ahn, Jin Seok Ahn, Jong-Mu Sun, Sehhoon Park, Young Mog Shim, Jae Ill Zo, Yong Soo Choi, Hong Kwan Kim, Jong Ho Cho, Sumin Shin, Jae Won Choi, Yeong Jeong Jeon, Je-Gun Joung, Se-Hoon Lee, Yoon-La Choi, Jinyeong Lim, Hyun Ae Jung
Supplementary Data from Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82a2da032a763ea163cf4bbda87cc5a6
https://doi.org/10.1158/1078-0432.22486479.v1
https://doi.org/10.1158/1078-0432.22486479.v1